药物调节内动脉瘤发育和破裂的药物调节
Alex Crane1, Regan M Shanahan1, Joseph S Hudson1
1Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Journal of clinical medicine
|June 19, 2024
概括
本综述探讨了用于管理内动脉瘤 (IA) 的药物策略. 虽然阿司匹林等一些药物表现有前途,但其他药物有不确定的证据,这凸显了IA药理管理需要进一步研究的需要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 血管医学 血管医学
背景情况:
- 内动脉瘤 (IAs) 具有显著的破裂风险,需要有效的管理策略.
- 目前的治疗方法包括内血管和微手术干预,但药理学方法提供了补充或替代选择.
- 了解IA的病理生理学揭示了炎症是预防和治疗的关键目标.
研究的目的:
- 提供对内动脉瘤的药物管理策略的最新摘要.
- 审查证据支持各种药物的有效性,以防止IA发展和破裂.
- 突出显示有保护作用的药物和那些没有确的发现的药物.
主要方法:
- 对IA药物干预现有研究的文献综述.
- 在IA病理生理学中分析针对炎症和新陈代谢的药物的证据.
- 评估与阿司匹林,RAAS抑制剂,COX-2抑制剂,他类药物和ADP抑制剂相关的发现.
主要成果:
- 乙盐酸和氨酸- ангиотензин- 阿尔多斯特系统 (RAAS) 抑制剂显示出对IA的保护作用的一些证据.
- 对选择性COX-2抑制剂,他类药物,ADP抑制剂和其他影响新陈代谢的药物的研究给出了关于它们对动脉瘤生长或破裂的影响的不确定的结果.
- 该审查综合了有关IA管理中药物疗效的现有证据.
结论:
- 药理管理可以补充对内动脉瘤的现有干预措施.
- 一些药物,包括阿司匹林和RAAS抑制剂,显示出潜在的保护性益处.
- 需要进一步的研究来澄清其他药物类别在预防IA进展和破裂中的作用.
更多相关视频
11:58Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
Published on: August 11, 2015
15.5K
11:07Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique
Published on: October 1, 2017
11.1K
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
The Blood-brain Barrier
47.2K
Overview
47.2K
